Physician profile
Weldon J Mallgren
NPI 1841384021
$793.89
in general payments reported to CMS, 2019-2025
13 companies · $84.15 in 2025
The $84.15 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $67.76 · 2021: $149 · 2022: $38.41 · 2023: $132 · 2024: $199 · 2025: $84.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $178.67 | 2019-2023 | Spravato, Invega Trinza, Invega Sustenna |
| Alkermes, INC. | $125.17 | 2024 | Lybalvi |
| Indivior INC. | $95.18 | 2020-2023 | Perseris |
| Teva Pharmaceuticals USA, INC. | $74.22 | 2024-2025 | Uzedy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $72.48 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $45.99 | 2025 | |
| Supernus Pharmaceuticals, INC. | $44.71 | 2023 | Qelbree |
| Abbvie INC. | $43.97 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $31.74 | 2019-2024 | Abilify Maintena |
| Vanda Pharmaceuticals INC. | $25.55 | 2019 | |
| Sunovion Pharmaceuticals INC. | $23.73 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $21.37 | 2025 | Cobenfy |
| Shire North American Group INC | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weldon Mallgren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.